Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/1998
08/27/1998WO1998027930A3 New use of aminopiperazine derivatives
08/27/1998WO1998026780A3 Flat medicament preparation for the application and release of buprenorphine or a pharmacologically comparable substance in the buccal cavity, and method of producing the same
08/27/1998WO1998025640A3 Novel methods for testing inhibitors of paired helical filaments and uses for treatment of alzheimer's disease
08/27/1998WO1998024782A3 Substituted pyrimidine compounds and their use
08/27/1998WO1998022441A3 N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions, and methods for inhibiting beta-amyloid peptide and/or its synthesis
08/27/1998DE19707628A1 Oxazolidinone Oxazolidinones
08/27/1998CA2281890A1 Method of treating psychological and metabolic disorders using igf or igf/igfbp-3
08/27/1998CA2281800A1 7a-heterocycle-substituted hexahydro-1h-pyrrolizine compounds useful in controlling chemical synaptic transmission
08/27/1998CA2281564A1 Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds
08/27/1998CA2281509A1 Use of substituted (5,6)-dihydronaphthalenyl compounds having retinoid-like activity to prevent or reduce ischemic injury
08/27/1998CA2278577A1 Assay for disease related conformation of a protein
08/26/1998EP0860506A1 Human protein kinase hYAKI (HOACF 72)
08/26/1998EP0860502A1 cDNA clone HDPBI30 that encodes a novel human 7-transmembrane receptor
08/26/1998EP0860445A1 New nucleotide sequences for the cell cycle regulated expression of structural genes
08/26/1998EP0859840A1 Biologically active eph family ligands
08/26/1998EP0859787A1 G-protein coupled receptor hnfds78
08/26/1998EP0859784A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation
08/26/1998EP0859779A1 Interleukin converting enzyme and apoptosis
08/26/1998EP0859777A1 8-azabicyclo 3.2.1]oct-2-ene derivatives, their preparation and use
08/26/1998EP0859776A1 Compounds derived from oxazolidin-2-one and preparation and therapeutical use thereof
08/26/1998EP0859775A1 Compounds derived from 3-(benzofuran-5-yl)oxazolidin-2-one, preparation method therefor and therapeutical use thereof
08/26/1998EP0859773A1 Phenol derivatives with pharmaceutical activity
08/26/1998EP0859766A1 Chiral methyl phenyl oxazolidinones
08/26/1998EP0859763A1 Dihydrophthalazine antagonists of excitatory amino acid receptors
08/26/1998EP0859762A1 Cytokine production inhibitors, formulations thereof and their use in medicine, and methods for their identification
08/26/1998EP0859760A1 Tricyclic pyrrolidine derivatives as calcium channel antagonists
08/26/1998EP0859614A1 Rotamase enzyme activity inhibitors
08/26/1998EP0739336B1 Gem-disubstituted azacyclic tachykinin antagonists
08/26/1998EP0674622B1 Tetrahydrocarbazole derivatives as 5-ht1-like agonists
08/26/1998EP0673360B1 Aminomethylindans, -benzofuranes and -benzothiophenes
08/26/1998EP0656015B1 New nimesulide salt cyclodextrin inclusion complexes
08/26/1998CN1191542A Nor-pregnanes for inducing hypothalamic effects
08/26/1998CN1191534A Oxazolidinone derivs, their preparation and therapeutical use
08/26/1998CN1191533A 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivs. as neurokinin receptor antagonists
08/26/1998CN1191486A Use of unsubstd and substd. N-(pyrrol-1-yl) pyridinamines as anticonvulsant agents
08/26/1998CN1191481A Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
08/26/1998CN1191134A Medicine for adjusting cranial nerve function
08/26/1998CN1191111A Process for preparing pharmaceutical composition containing N-acyl-2,3-benzodiazepine derivatives as active ingredient
08/25/1998US5798448 AL-1 neurotrophic factor antibodies
08/25/1998US5798392 Sulfonyl fluorides for the treatment of Alzheimer's disease
08/25/1998US5798367 Indazolecarboxamides
08/25/1998US5798366 Treating genetic disorder by administering a 1,5-iminosugar
08/25/1998US5798363 Use for tachykinin antagonists to treat emesis
08/25/1998US5798361 5H-thiazolo 3,2-a!pyrimidin-5-one derivatives
08/25/1998US5798355 Inhibitors of rotamase enzyme activity
08/25/1998US5798353 Treating eating disorder, obesity, diabetes, psychological disorder, sexual disorder, psychosis, memory disorder
08/25/1998US5798352 Antithrombotic amidinotetrahydropyridylalanine derivatives
08/25/1998US5798350 Tricyclic dibenz(b,f)oxepines and dibenzo(b,f)thiepines for treating schizophrenia and anxiety
08/25/1998US5798347 Dehydroepiandrosterone and dehydroepiandrosterone sulfate used for inhibiting proliferation of ovarian cancer
08/25/1998US5798213 Monoclonal antibodies
08/25/1998US5798093 Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions and pruritus therewith
08/25/1998CA2071193C Sulfonamides
08/25/1998CA2031714C R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them
08/24/1998CA2220855A1 Cdna clone hdpb130 that encodes a novel human 7-transmembrane receptor
08/20/1998WO1998036072A1 Neurturin receptor
08/20/1998WO1998036069A1 Novel human mago nashi protein
08/20/1998WO1998035967A2 Biazacyclic crf antagonists
08/20/1998WO1998035957A1 Amide derivatives as selective neuropeptide y receptor antagonists
08/20/1998WO1998035951A2 New aminopiperazine derivatives
08/20/1998WO1998035950A1 Benzofurazan compounds which enhance ampa receptor activity
08/20/1998WO1998035948A1 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists
08/20/1998WO1998035947A1 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-thiones derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists
08/20/1998WO1998035946A1 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists
08/20/1998WO1998035945A1 4-aminoalkoxy-1h-benzimidazole derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists
08/20/1998WO1998035943A1 4-aminoethoxyindazole derivatives
08/20/1998WO1998035942A1 4-aminoethoxyindazole derivatives
08/20/1998WO1998035681A1 Oxacarbazepine film-coated tablets
08/20/1998WO1998035680A1 Method for the treatment of drug addiction and homeopathic remedy
08/20/1998WO1998035679A1 Stabilization of naloxonhydrochlorid
08/20/1998WO1998035675A1 Method of using neurotrophic sulfonamide compounds
08/20/1998WO1998035671A1 Remedies for parkinsonism
08/20/1998WO1998027058A3 N-piperazin-1-ylphenyl-benzamide derivatives
08/20/1998WO1998014596A3 Disease associated protein tyrosine phosphatases
08/20/1998EP0880352A3 Stabilization of naloxonhydrochlorid
08/20/1998CA2281525A1 Biazacyclic crf antagonists
08/20/1998CA2280896A1 Novel human mago nashi protein
08/20/1998CA2280742A1 Method of using neurotrophic sulfonamide compounds
08/20/1998CA2278757A1 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists
08/20/1998CA2278747A1 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists
08/20/1998CA2278746A1 4-aminoethoxyindazole derivatives
08/20/1998CA2278718A1 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-thiones derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists
08/20/1998CA2278700A1 4-aminoalkoxy-1h-benzimidazole derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists
08/20/1998CA2251368A1 Amide derivatives as selective neuropeptide y receptor antagonists
08/19/1998EP0859056A2 Human nerve growth factor
08/19/1998EP0859054A1 Drug binding protein
08/19/1998EP0859053A1 Novel G-protein coupled receptor (HTADX50)
08/19/1998EP0859004A1 Piperidine derivatives having anxiolytic effect
08/19/1998EP0858461A1 Fused tropane-derivatives as neurotransmitter reuptake inhibitors
08/19/1998EP0858444A1 Cyclopentyl tachykinin receptor antagonists
08/19/1998EP0858443A1 4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
08/19/1998EP0858442A1 4-phenyl-4-oxo-2-butenoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
08/19/1998EP0858333A1 Thiamorphinans with neuroprotective activity
08/19/1998EP0858328A2 Stable compositions containing n-propargyl-1-aminoindan
08/19/1998EP0696291B1 Pyrido(1,2,3-de)quinoxaline derivatives, process for preparing the same and their use in medicaments
08/19/1998EP0667860B1 Aza spiro alkanes derivatives as therapeutic agents
08/19/1998EP0663825B1 USE OF MELATONIN in low oral doses TO INDUCE SLEEP
08/19/1998EP0618809B1 Bradykinin type peptides
08/19/1998EP0454818B1 Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses
08/19/1998CN1190970A Resolution of 1-azabicyclo £2.2.2| octan-3-amine, 2-(diphenylmethyl)-N-££2-methoxy-5-(1-methylethyl) phenyl| methyl|
08/19/1998CN1190968A Piperazine derivatives and their use as 5-HT1A antagonists
1 ... 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 ... 1833